United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2018_register
executive
2018-04-13
article
Agency Information Collection Activities; Proposed Collection; Comment Request; Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products
Notices
D09002ee1bdb91701
D09002ee1bdb91779
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on ``Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products.''
83 FR 16108
https://www.govinfo.gov/app/details/FR-2018-04-13/2018-07684
2018-07684
fr13ap18-63
4164-01-P
Docket No. FDA-2018-N-1111
https://www.govinfo.gov/app/details/FR-2018-04-13/2018-07684
https://www.govinfo.gov/content/pkg/FR-2018-04-13/html/2018-07684.htm
https://www.govinfo.gov/content/pkg/FR-2018-04-13/pdf/2018-07684.pdf
3 p.
16108
16110
83 FR 16108
Agency Information Collection Activities; Proposed Collection; Comment Request; Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products; Federal Register Vol. 83, Issue
NOTICE
2018-07684
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2018-06-12
Docket No. FDA-2018-N-1111
4164-01-P
2018-07684
Notice.
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on ``Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products.''
Submit either electronic or written comments on the collection of information by June 12, 2018.
Domini Bean, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-5733, PRAStaff@fda.hhs.gov.
Agency Information Collection Activities; Proposals, Submissions, and Approvals:
Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products
,
PRAStaff@fda.hhs.gov
https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf
https://www.regulations.gov
Federal Register
Vol. 83, no. 72
Office of the Federal Register, National Archives and Records Administration
2018-04-13
continuing
daily
deposited
born digital
255 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2018-04-13
P0b002ee19a082251
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr13ap18
https://www.govinfo.gov/app/details/FR-2018-04-13
https://www.govinfo.gov/content/pkg/FR-2018-04-13/pdf/FR-2018-04-13.pdf
https://www.govinfo.gov/content/pkg/FR-2018-04-13/xml/FR-2018-04-13.xml
fdlp
15937
16181
DGPO
2018-04-13
2023-04-28
FR-2018-04-13
machine generated
eng
FR
FR-2018-04-13
83
72